Updated Practice Guidance on Diagnosis and Management of Hepatocellular Carcinoma

Experts have updated guidance based on the most recent evidence, augmenting the 2010 AASLD clinical guideline.

Sponsoring Organization: American Association for the Study of Liver Diseases (AASLD)

Target Audience: Hepatologists, gastroenterologists, medical oncologists

Background and Objective

Based on a review of the most recent evidence on the diagnosis, staging, and management of hepatocellular carcinoma (HCC), experts have provided supplementary guidance to the 2010 clinical guideline from the AASLD.

Key Recommendations

Surveillance

Conduct primary surveillance using ultrasound with or without alpha fetoprotein (AFP) testing every 6 months.
Do not use computed tomography or magnetic resonance imaging as primary surveillance modalities.
Continue HCC surveillance in patients with hepatitis C virus (HCV)–related cirrhosis who have cleared the virus.
Discont…

Reviewing Author

Atif Zaman, MD, MPH

Disclosures

Nothing to disclose